AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
DETECTION AND REDUCTION OF LEUKEMIC COLONIES IN AML - INFLUENCE OF CYTOKINES AND AUTOLOGOUS LAK-CELLS
Authors: BRAUN S SCHMETZER H GERHARTZ HH
Citation: S. Braun et al., DETECTION AND REDUCTION OF LEUKEMIC COLONIES IN AML - INFLUENCE OF CYTOKINES AND AUTOLOGOUS LAK-CELLS, Experimental hematology, 26(8), 1998, pp. 341-341
RANDOMIZED PHASE-III STUDY OF INTERLEUKIN-3 (RHIL-3) AS ADJUVANT TO IEV-CHEMOTHERAPY FOR RELAPSING AGGRESSIVE LYMPHOMAS
Authors: GERHARTZ HH MANDELLI F PHILIP T TURA S HEINZ R GREIL R SENN HJ HUBER C BLAU W FARBER L SKLENAR I HAUS U
Citation: Hh. Gerhartz et al., RANDOMIZED PHASE-III STUDY OF INTERLEUKIN-3 (RHIL-3) AS ADJUVANT TO IEV-CHEMOTHERAPY FOR RELAPSING AGGRESSIVE LYMPHOMAS, Bone marrow transplantation, 22, 1998, pp. 11-11
THE USE OF DOSE-INTENSIFIED CHEMOTHERAPY IN THE TREATMENT OF METASTATIC NONSEMINOMATOUS TESTICULAR GERM-CELL TUMORS
Authors: BOKEMEYER C HARSTRICK A BEYER J METZNER B RUTHER U HARTMANN JT HOLSTEIN K DERIGS HG DEWIT R CASPER J SCHOFFSKI P KUHRER I ILLIGER HJ KEMPF B REICHLE A FOLLER A HOSSFELD DK FISCHER JT BERDEL WE GERHARTZ HH KIRCHNER H PFLUGER KH OSTERMANN H KANZ L SCHMOLL HJ
Citation: C. Bokemeyer et al., THE USE OF DOSE-INTENSIFIED CHEMOTHERAPY IN THE TREATMENT OF METASTATIC NONSEMINOMATOUS TESTICULAR GERM-CELL TUMORS, Seminars in oncology, 25(2), 1998, pp. 24-32
CLONALITY ANALYSIS AS A TOOL TO STUDY THE BIOLOGY AND RESPONSE TO THERAPY IN MYELODYSPLASTIC SYNDROMES
Authors: SCHMETZER HM POLECK B MITTERMULLER J DUELL T WILMANNS W GERHARTZ HH
Citation: Hm. Schmetzer et al., CLONALITY ANALYSIS AS A TOOL TO STUDY THE BIOLOGY AND RESPONSE TO THERAPY IN MYELODYSPLASTIC SYNDROMES, Leukemia, 11(5), 1997, pp. 660-666
INFLUENCE OF CYTOKINES ON CELL-DIFFERENTIATION IN ACUTE MYELOID-LEUKEMIA (AML) - A FLOW-CYTOMETRIC ANALYSIS
Authors: BRAUN S SCHMETZER H GERHARTZ HH
Citation: S. Braun et al., INFLUENCE OF CYTOKINES ON CELL-DIFFERENTIATION IN ACUTE MYELOID-LEUKEMIA (AML) - A FLOW-CYTOMETRIC ANALYSIS, Experimental hematology, 25(8), 1997, pp. 437-437
IMMUNOLOGICAL CLASSIFICATION OF CHRONIC MYELOID-LEUKEMIA DISTINGUISHES CHRONIC PHASE, IMMINENT BLASTIC TRANSFORMATION, AND ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: SCHMETZER HM GERHARTZ HH
Citation: Hm. Schmetzer et Hh. Gerhartz, IMMUNOLOGICAL CLASSIFICATION OF CHRONIC MYELOID-LEUKEMIA DISTINGUISHES CHRONIC PHASE, IMMINENT BLASTIC TRANSFORMATION, AND ACUTE LYMPHOBLASTIC-LEUKEMIA, Experimental hematology, 25(6), 1997, pp. 502-508
RANDOMIZED 3-ARM PHASE-III STUDY OF INTERLEUKIN-3 (IL-3), OR GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) AS AN ADJUVANT TO LOW-DOSES OF CYTOSINE-ARABINOSIDE (LD-ARAC) FOR THE TREATMENT OF HIGH-RISK MYELODYSPLASTIC SYNDROMES (HR-MDS)/
Authors: GERHARTZ HH ZWIERZINA H SUCIU S WALTHER J DARDENNE M NEUWIRTOVA R FENAUX P BEKSAC M HAROUSSEAU JL LOUWAGIE A THYSS A FIERE D COIFFIER B BAUMELOU F LABAR B SOLBU G WILLEMZE R
Citation: Hh. Gerhartz et al., RANDOMIZED 3-ARM PHASE-III STUDY OF INTERLEUKIN-3 (IL-3), OR GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) AS AN ADJUVANT TO LOW-DOSES OF CYTOSINE-ARABINOSIDE (LD-ARAC) FOR THE TREATMENT OF HIGH-RISK MYELODYSPLASTIC SYNDROMES (HR-MDS)/, Blood, 90(10), 1997, pp. 370-370
RANDOMIZED COMPARISON OF COPP ABVD VS. DOSE-ESCALATED AND TIME-ESCALATED COPP/ABVD WITH GM-CSF SUPPORT FOR ADVANCED HODGKINS-DISEASE/
Authors: GERHARTZ HH SCHWENKE H BAZARBASHI S THIEL E BLAU W HUHN D HEIMPEL H BROWN P SCHLIEMOK G ILLIGER HJ WALTHER J WILMANNS W CHARISSE G FARBER L HAUS U
Citation: Hh. Gerhartz et al., RANDOMIZED COMPARISON OF COPP ABVD VS. DOSE-ESCALATED AND TIME-ESCALATED COPP/ABVD WITH GM-CSF SUPPORT FOR ADVANCED HODGKINS-DISEASE/, Blood, 90(10), 1997, pp. 1731-1731
SUBCLASSIFICATION OF DIFFUSE LARGE B-CELL LYMPHOMAS ACCORDING TO THE KIEL CLASSIFICATION - DISTINCTION OF CENTROBLASTIC AND IMMUNOBLASTIC LYMPHOMAS IS A SIGNIFICANT PROGNOSTIC RISK FACTOR
Authors: ENGELHARD M BRITTINGER G HUHN D GERHARTZ HH MEUSERS P SIEGERT W THIEL E WILMANNS W AYDEMIR U BIERWOLF S GRIESSER H TIEMANN M LENNERT K
Citation: M. Engelhard et al., SUBCLASSIFICATION OF DIFFUSE LARGE B-CELL LYMPHOMAS ACCORDING TO THE KIEL CLASSIFICATION - DISTINCTION OF CENTROBLASTIC AND IMMUNOBLASTIC LYMPHOMAS IS A SIGNIFICANT PROGNOSTIC RISK FACTOR, Blood, 89(7), 1997, pp. 2291-2297
INTERLEUKIN-3 PLUS LOW-DOSE CYTOSINE-ARABINOSIDE FOR ADVANCED MYELODYSPLASIA - A PILOT-STUDY
Authors: GERHARTZ HH ZWIERZINA HH WALTHER J FENAUX P HAYAT M JACOBS A HOFFBRAND AV DARDENNE M SOLBU G SUCIU S AMADORI S WILLEMZE R
Citation: Hh. Gerhartz et al., INTERLEUKIN-3 PLUS LOW-DOSE CYTOSINE-ARABINOSIDE FOR ADVANCED MYELODYSPLASIA - A PILOT-STUDY, Cancer investigation, 14(4), 1996, pp. 299-306
RANDOMIZED-3 ARMED PHASE-III STUDY OF INTERLEUKIN-3 (IL-3), OR GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) AS AN ADJUVANT TO LOW-DOSES OF CYTOSINE-ARABINOSIDE (LD-ARAC) FOR THE TREATMENT OF HIGH-RISK MYELODYSPLASTIC SYNDROMES (HR-MDS)/
Authors: GERHARTZ HH WALTHER JH NEUWIRTOVA R FENAUX P HAROUSSEAU JL BEKSAC M ZWIERZINA H BAUMELOU E FIERE D LOUWAGIE A THYSS A DARDENNE M SOLBU G SUCIU S ZITTOUN R
Citation: Hh. Gerhartz et al., RANDOMIZED-3 ARMED PHASE-III STUDY OF INTERLEUKIN-3 (IL-3), OR GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) AS AN ADJUVANT TO LOW-DOSES OF CYTOSINE-ARABINOSIDE (LD-ARAC) FOR THE TREATMENT OF HIGH-RISK MYELODYSPLASTIC SYNDROMES (HR-MDS)/, Blood, 88(10), 1996, pp. 2309-2309
DETECTION OF ACUTE MYELOID LEUKEMIC-CELLS IN COMPLETE REMISSION AND IN EXTRAMEDULLARY SITES BY CLONAL ANALYSES
Authors: SCHMETZER HM WILMANNS W GERHARTZ HH
Citation: Hm. Schmetzer et al., DETECTION OF ACUTE MYELOID LEUKEMIC-CELLS IN COMPLETE REMISSION AND IN EXTRAMEDULLARY SITES BY CLONAL ANALYSES, Acta haematologica, 96(2), 1996, pp. 83-87
PERSPECTIVE OF RHGM-CSF IN THE TREATMENT OF NEUTROPENIC INFECTIONS AND AGGRESSIVE LYMPHOMAS
Authors: GERHARTZ HH
Citation: Hh. Gerhartz, PERSPECTIVE OF RHGM-CSF IN THE TREATMENT OF NEUTROPENIC INFECTIONS AND AGGRESSIVE LYMPHOMAS, Stem cells, 13(5), 1995, pp. 472-476
RANDOMIZED PHASE-III STUDY OF INTERLEUKIN-3 (RHIL-3) IN IEV-CHEMOTHERAPY OF RELAPSING AGGRESSIVE LYMPHOMAS
Authors: GERHARTZ HH MANDELLI F PHILIP T TURA S HEINZ R GREIL R SENN HJ HUBER C BLAU W FARBER L SKLENAR I HAUS U
Citation: Hh. Gerhartz et al., RANDOMIZED PHASE-III STUDY OF INTERLEUKIN-3 (RHIL-3) IN IEV-CHEMOTHERAPY OF RELAPSING AGGRESSIVE LYMPHOMAS, Blood, 86(10), 1995, pp. 202-202
A RANDOMIZED PHASE-II STUDY OF LOW-DOSE CYTOSINE-ARABINOSIDE (LD-ARAC) PLUS GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (RHGM-CSF) IN MYELODYSPLASTIC SYNDROMES (MDS) WITH A HIGH-RISK OF DEVELOPING LEUKEMIA
Authors: GERHARTZ HH MARCUS R DELMER A ZWIERZINA H SUCIU S DARDENNE M SOLBU G DEWITTE T JACOBS A VISANI G FIERE D SONNEVELD P LABAR B HOFFBRAND AV FENAUX P HAYAT M THYSS A DEBUSSCHER L COIFFIER B SIZOO W WILLEMZE R RIBEIRO M MANDELLI F BURGHOUTS G CAUCHIE C PEETERMANS M ROOZENDAAL KJ GOUDSMIT R DOUER D CASTOLDI GL STERN A ZITTOUN R
Citation: Hh. Gerhartz et al., A RANDOMIZED PHASE-II STUDY OF LOW-DOSE CYTOSINE-ARABINOSIDE (LD-ARAC) PLUS GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (RHGM-CSF) IN MYELODYSPLASTIC SYNDROMES (MDS) WITH A HIGH-RISK OF DEVELOPING LEUKEMIA, Leukemia, 8(1), 1994, pp. 16-23
LATE-ONSET OF NEUROTOXICITY WITH CYCLOSPORINE
Authors: WELGELUSSEN UC GERHARTZ HH
Citation: Uc. Welgelussen et Hh. Gerhartz, LATE-ONSET OF NEUROTOXICITY WITH CYCLOSPORINE, Lancet, 343(8892), 1994, pp. 293-293
RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ASADJUNCT TO CHEMOTHERAPY IN AGGRESSIVE NON-HODGKINS-LYMPHOMAS
Authors: GERHARTZ HH ENGELHARD M BRITTINGER G SCHLIMOK G THIEL E HUBER C EMMERICH B SCHADEK C BRANDMAIER R STERN AC LENNERT K
Citation: Hh. Gerhartz et al., RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ASADJUNCT TO CHEMOTHERAPY IN AGGRESSIVE NON-HODGKINS-LYMPHOMAS, Seminars in oncology, 21(6), 1994, pp. 25-28
QUESTIONS ABOUT THE ROLE OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATINGFACTOR AS ADJUNCT TO NON-HODGKINS-LYMPHOMA CHEMOTHERAPY - REPLY
Authors: GERHARTZ HH ENGELHARD M BRITTINGER G
Citation: Hh. Gerhartz et al., QUESTIONS ABOUT THE ROLE OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATINGFACTOR AS ADJUNCT TO NON-HODGKINS-LYMPHOMA CHEMOTHERAPY - REPLY, Blood, 84(5), 1994, pp. 1692-1692
IMMUNOLOGICAL CLASSIFICATION OF CHRONIC MYELOID-LEUKEMIA DISTINGUISHES CHRONIC PHASE, IMMINENT BLASTIC TRANSFORMATION AND ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: SCHMETZER HM GERHARTZ HH
Citation: Hm. Schmetzer et Hh. Gerhartz, IMMUNOLOGICAL CLASSIFICATION OF CHRONIC MYELOID-LEUKEMIA DISTINGUISHES CHRONIC PHASE, IMMINENT BLASTIC TRANSFORMATION AND ACUTE LYMPHOBLASTIC-LEUKEMIA, Blood, 84(10), 1994, pp. 10000153-10000153
INTERLEUKIN-3 (IL-3) PLUS LOW-DOSE ARA-C CAN INDUCE TRUE COMPLETE RESPONSES IN MYELODYSPLASTIC SYNDROMES (MDS)
Authors: GERHARTZ HH ZWIERZINA H WALTHER J SCHMETZER H DARDENNE M SOLBU G FENAUX P HAYAT M JACOBS A HOFFBRAND AV SUCIU S
Citation: Hh. Gerhartz et al., INTERLEUKIN-3 (IL-3) PLUS LOW-DOSE ARA-C CAN INDUCE TRUE COMPLETE RESPONSES IN MYELODYSPLASTIC SYNDROMES (MDS), Blood, 84(10), 1994, pp. 10000316-10000316
ACUTE MYELOID-LEUKEMIA (AML) CAN BE OLIGOCLONAL
Authors: SCHMETZER HM GERHARTZ HH
Citation: Hm. Schmetzer et Hh. Gerhartz, ACUTE MYELOID-LEUKEMIA (AML) CAN BE OLIGOCLONAL, Leukemia, 7(12), 1993, pp. 1965-1970
RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE-III STUDY OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AS ADJUNCT TO INDUCTION TREATMENT OF HIGH-GRADE MALIGNANT NON-HODGKINS-LYMPHOMAS
Authors: GERHARTZ HH ENGELHARD M MEUSERS P BRITTINGER G WILMANNS W SCHLIMOK G MUELLER P HUHN D MUSCH R SIEGERT W GERHARTZ D HARTLAPP JH THIEL E HUBER C PESCHL C SPANN W EMMERICH B SCHADEK C WESTERHAUSEN M PEES HW RADTKE H ENGERT A TERHARDT E SCHICK H BINDER T FUCHS R HASFORD J BRANDMAIER R STERN AC JONES TC EHRLICH HJ STEIN H PARWARESCH M TIEMANN M LENNERT K
Citation: Hh. Gerhartz et al., RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE-III STUDY OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AS ADJUNCT TO INDUCTION TREATMENT OF HIGH-GRADE MALIGNANT NON-HODGKINS-LYMPHOMAS, Blood, 82(8), 1993, pp. 2329-2339
SUPPRESSION OF RESIDUAL LEUKEMIC PROGENITORS (CFU-L) IN COMPLETE REMISSION OF ACUTE MYELOID-LEUKEMIA BY AUTOLOGOUS LAK CELLS
Authors: GERHARTZ HH SCHMETZER H UNGER H MAYER F
Citation: Hh. Gerhartz et al., SUPPRESSION OF RESIDUAL LEUKEMIC PROGENITORS (CFU-L) IN COMPLETE REMISSION OF ACUTE MYELOID-LEUKEMIA BY AUTOLOGOUS LAK CELLS, Blood, 82(10), 1993, pp. 10000125-10000125
INTERLEUKIN-3 ENHANCES THE ENDOGENOUS LEUKOTRIENE PRODUCTION
Authors: DENZLINGER C WALTHER J WILMANNS W GERHARTZ HH
Citation: C. Denzlinger et al., INTERLEUKIN-3 ENHANCES THE ENDOGENOUS LEUKOTRIENE PRODUCTION, Blood, 81(9), 1993, pp. 2466-2468
DIFFERENTIAL ACTIVATION OF THE ENDOGENOUS LEUKOTRIENE BIOSYNTHESIS BY2 DIFFERENT PREPARATIONS OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATINGFACTOR IN HEALTHY-VOLUNTEERS
Authors: DENZLINGER C TETZLOFF W GERHARTZ HH POKORNY R SAGEBIEL S HABERL C WILMANNS W
Citation: C. Denzlinger et al., DIFFERENTIAL ACTIVATION OF THE ENDOGENOUS LEUKOTRIENE BIOSYNTHESIS BY2 DIFFERENT PREPARATIONS OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATINGFACTOR IN HEALTHY-VOLUNTEERS, Blood, 81(8), 1993, pp. 2007-2013
Risultati: 1-25 | 26-26